JP2011513244A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513244A5
JP2011513244A5 JP2010547917A JP2010547917A JP2011513244A5 JP 2011513244 A5 JP2011513244 A5 JP 2011513244A5 JP 2010547917 A JP2010547917 A JP 2010547917A JP 2010547917 A JP2010547917 A JP 2010547917A JP 2011513244 A5 JP2011513244 A5 JP 2011513244A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
diazepan
diphenylethyl
naphthoamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010547917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513244A (ja
JP5503557B2 (ja
Filing date
Publication date
Priority claimed from US12/391,720 external-priority patent/US8008291B2/en
Application filed filed Critical
Publication of JP2011513244A publication Critical patent/JP2011513244A/ja
Publication of JP2011513244A5 publication Critical patent/JP2011513244A5/ja
Application granted granted Critical
Publication of JP5503557B2 publication Critical patent/JP5503557B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010547917A 2008-02-29 2009-02-27 3−アミノアルキル−1,4−ジアゼパン−2−オンメラノコルチン−5受容体アンタゴニスト Expired - Fee Related JP5503557B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3289408P 2008-02-29 2008-02-29
US61/032,894 2008-02-29
US12/391,720 US8008291B2 (en) 2008-02-29 2009-02-24 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
US12/391,720 2009-02-24
PCT/AU2009/000230 WO2009105823A1 (en) 2008-02-29 2009-02-27 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2011513244A JP2011513244A (ja) 2011-04-28
JP2011513244A5 true JP2011513244A5 (enExample) 2014-02-27
JP5503557B2 JP5503557B2 (ja) 2014-05-28

Family

ID=41015440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010547917A Expired - Fee Related JP5503557B2 (ja) 2008-02-29 2009-02-27 3−アミノアルキル−1,4−ジアゼパン−2−オンメラノコルチン−5受容体アンタゴニスト

Country Status (16)

Country Link
US (1) US8008291B2 (enExample)
EP (1) EP2257534B1 (enExample)
JP (1) JP5503557B2 (enExample)
KR (1) KR101620114B1 (enExample)
CN (1) CN102007105B (enExample)
AU (1) AU2009219106B2 (enExample)
BR (1) BRPI0907903B1 (enExample)
CA (1) CA2716250C (enExample)
DK (1) DK2257534T3 (enExample)
ES (1) ES2445456T3 (enExample)
IL (1) IL207700A (enExample)
MX (1) MX2010009487A (enExample)
NZ (1) NZ587363A (enExample)
PT (1) PT2257534E (enExample)
RU (1) RU2530017C2 (enExample)
WO (1) WO2009105823A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009219107B2 (en) * 2008-02-29 2013-11-21 Marp Therapeutics Pty Ltd Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
WO2010096853A1 (en) * 2009-02-27 2010-09-02 Mimetica Pty Ltd Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
CN109956947A (zh) * 2017-12-25 2019-07-02 江苏恒瑞医药股份有限公司 一种cns抑制剂的新晶型、制备方法及用途
CN115381955B (zh) * 2021-05-24 2024-05-17 中国科学技术大学 黑皮质素受体mc5r的用途
KR102703324B1 (ko) * 2022-11-08 2024-09-06 국민대학교산학협력단 아미노벤즈이미다졸 유도체 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502883A (ja) 1992-08-21 1996-04-02 ヴァー ファルム アーベー ヒトメラノサイト刺激ホルモンレセプター
US5622860A (en) 1994-02-17 1997-04-22 The Regents Of The University Of Michigan Genes encoding melanocortin receptors
WO1996022304A1 (en) 1995-01-20 1996-07-25 Molecumetics, Ltd. Conformationally constrained reverse-turn library and methods relating thereto
US5929237A (en) 1995-10-27 1999-07-27 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
AU7162698A (en) 1997-04-25 1998-11-24 Regents Of The University Of California, The Dipeptide surrogates containing asparagine-derived tetrahydropyrimidinones
AUPP254898A0 (en) 1998-03-24 1998-04-23 University Of Queensland, The Peptide turn mimetics
AU742747B2 (en) 1998-03-24 2002-01-10 Mimetica Pty Ltd Peptide turn mimetics
CA2349848A1 (en) 1998-11-09 2000-05-18 Merck & Co., Inc. Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
EP1289965B1 (en) * 2000-05-25 2005-10-26 F. Hoffmann-La Roche Ag Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
CA2462200A1 (en) * 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US20030110518A1 (en) 2001-09-28 2003-06-12 Houseknecht Karen L. Melanocortin-5 receptor sequences and uses thereof
US6916812B2 (en) * 2001-10-09 2005-07-12 Bristol-Myers Squibb Company Alpha-aminoamide derivatives as melanocortin agonists
SG176310A1 (en) 2001-11-08 2011-12-29 Ortho Mcneil Pharm Inc Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
US7319107B2 (en) 2001-11-08 2008-01-15 Johnson & Johnson Consumer Companies, Inc. 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
AU2003216274A1 (en) * 2002-02-11 2003-09-04 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
BRPI0411673A (pt) * 2003-06-20 2006-08-08 Amgen Inc composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
US7281642B2 (en) * 2004-09-16 2007-10-16 Prime Time Toys, Ltd. Squirting toy
WO2008017852A1 (en) 2006-08-11 2008-02-14 Palatin Technologies, Inc. Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators
AU2009219107B2 (en) * 2008-02-29 2013-11-21 Marp Therapeutics Pty Ltd Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor

Similar Documents

Publication Publication Date Title
JP2011513245A5 (enExample)
RU2497822C2 (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
JP6207399B2 (ja) P2x4受容体拮抗剤
JP2005526723A5 (enExample)
JP2011518158A5 (enExample)
JP2004534755A5 (enExample)
JP2015517981A5 (enExample)
JP2007519754A5 (enExample)
JP2012502986A5 (enExample)
CA2409841C (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
RU2007137987A (ru) Цис-2, 4, 5-триарилимидазолины и их применение в качестве противораковых лекарственных средств
JP2003507328A5 (enExample)
RU2008141510A (ru) Новые соединения
JP2008534511A5 (enExample)
WO2017195216A4 (en) Cyclopropyl-amide compounds as dual lsd1/hdac inhibitors
US20150297581A1 (en) Rho kinase inhibitors
JP2013537887A5 (enExample)
HRP20150442T1 (hr) Sredstva za izazivanje apoptoze za lijeäśenje raka i imunih i autoimunih bolesti
JP2005524668A5 (enExample)
JP2004300156A (ja) 新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法
SK287555B6 (sk) 4-(Fenylpiperazinylmetyl)benzamidové deriváty a ich použitie na liečbu bolesti, anxiety alebo gastrointestinálnych porúch
NZ724602A (en) Ror-gamma modulators and uses thereof
RU2006101541A (ru) Производные пиперазина и способ их применения
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
JP2008513464A5 (enExample)